Buy Medications no RX

A state court jury hearing a Vioxx product liability case brought by a postal worker against the drug maker Merck deliberated about an hour Tuesday without reaching a verdict and was then sent home for the night after getting the case earlier in the day. Read more…

The FDA issued a warning last week that the multiple sclerosis drug Avonex, made by Biogen Idec, might cause severe liver damage in rare cases. Read more…

A Texas family's wrongful death suit against Humana Health Plan of Texas, Inc. is about to go to trial. At the heart of the case lies the family's discovery that the deceased should never have been prescribed the Vioxx she was taking. Read more…

A bill pending in Oregon's state Senate that would adjust the state's statute of limitations to allow Vioxx-related injury suits to move forward has stalled in the Senate's chambers. Now, frustrated Vioxx users who say the painkiller caused their heart problems are trying to revive the bill that would allow them to file lawsuits against the drug's maker. Determined opposition from the drug industry is the culprit. Read more…

Merck & Co. identified 109 Vioxx-related class action lawsuits around the United States, according to a submission by the company in the federal multidistrict litigation In Re: Vioxx Products Liability Litigation (MDL 1657, E.D. La.). Read more…

The Food and Drug Administration has demanded that all pharmaceutical companies change their warning labels on a huge swathe of painkillers to warn consumers about possible stomach and heart problems the drugs may cause. The FDA's edict covers both prescription and OTC (over-the-counter) drugs. Read more…

Despite an April study and a follow-up FDA investigation linking Viagra and other impotence drugs to a rare form of blindness, even the most ardent drug litigators are toning down their excitement over the prospect of successful suits. Read more…

A new study suggests that women taking daily amounts of non-aspirin painkillers - such as an extra-strength Tylenol - are more likely to develop high blood pressure than those who don't. Read more…

Florida Attorney General Charlie Crist has filed a lawsuit accusing three generic drug makers of 25 million dollars in Medicaid fraud. Read more…

The manufacturer of Zicam Cold Remedy has agreed to pay $12 million to settle 340 lawsuits brought by consumers who claim the popular over-the-counter zinc nasal gel damaged or destroyed their sense of smell. Read more…

Regulation of the Pharmaceutical Industryeds. John Abraham and Helen Lawton SmithPalgrave Macmillan, 2003. ?55This densely informative collection of studies addresses a huge and complicated topic. Read more…

A pharmacy care program for elderly patients increases medication adherence according to a study appearing in JAMA. Read more…

FDA informs public of nationwide recall of 500mg strength store-brand acetaminophen caplets. Read more…

Health boards across Scotland are looking into introducing registers for all medical staff to allow them to declare if they have any links with drug companies. The news comes following fears that some of the world's pharmaceutical giants have too much influence over what drugs some doctors prescribe. NHS Greater Glasgow has told the Herald that following a consultation it hopes to have a register, which would be publicly available, in place by June. Read more…

The Medicines and Healthcare products Regulatory Agency (MHRA) has found that Napp Pharmaceuticals broke its advertising rules. A complaint was lodged about the firm's advert for the painkiller BuTrans (buprenorphine matrix patch) in the British Medical Journal in November 2005. Read more…

Dr Sami Timimi gives a lucid account of the socio-cultural context behind the rising rates of prescription of psycho-stimulants for children. Read more…

Gordon Brown’s recent speech on the limits of market mechanisms did not go quite far enough, argues Margaret CookWhen great men make great speeches it has been remarked that the content is often not as impressive in the reading as in the hearing. Read more…

Proposals to deregulate the market for community pharmacy may end up cutting services patients need, says Richard LewisTo the casual observer, the Office of Fair Trading seems to have it in for community pharmacists. Read more…

Most health research is driven by commercial interests, leading to significant gaps in healthcare understanding, a report from the King’s Fund thinktank concludes. Read more…

Thousands of gene patents have been issued – yet in most cases they are not inventions, and patenting harms the public interest, warns Sue MayerFor some years a fierce argument has been raging over whether genes should be patentable. Read more…

Many deaths in developing countries could be avoided if essential drug prices were lowered. Ken Bluestone explains how pharmaceutical companies are being urged to take their social responsibilities seriouslyWhy not lower drugs prices systematically for developing countries? Read more…

Too many people who visit their GP with mental health problems are being offered drugs as the only option, according to the mental health charity Mind which has launched a campaign for more choice. Read more…

Dear healthmatters — Further to your report ‘Global pressure leads to falling drug prices’ (issue 44) the pharmaceutical industry is indeed fighting hard – and dirty. Read more…

Consultant psychiatrists joined forces with mental health service user groups in July to demonstrate against the ‘hijacking’ of mental health care by the pharmaceutical industry. Read more…

Read more…